Kera-FM 5% Topical Solution is a dual-action formulation combining Minoxidil 5% w/v and Finasteride 0.1% w/v, designed for the treatment of androgenetic alopecia in both men and women. Minoxidil, a potent vasodilator, promotes hair regrowth by enhancing follicular blood flow and prolonging the anagen phase of the hair cycle, thereby stimulating dormant hair follicles. Finasteride, a selective 5-alpha-reductase inhibitor, reduces the conversion of testosterone to dihydrotestosterone (DHT), a key androgen responsible for follicular miniaturization and progressive hair loss. The topical delivery system of Kera-FM allows localized action with minimized systemic absorption, potentially reducing the risk of systemic side effects commonly associated with oral finasteride. This combination therapy offers a synergistic effect, addressing both the hormonal and vascular components of hair thinning. Kera-FM 5% Topical Solution is applied once or twice daily to the affected scalp areas, ensuring consistent exposure to active ingredients. Patients should use the product continuously for several months to observe visible improvement, with regular monitoring advised to assess efficacy and tolerability. Common adverse effects may include scalp irritation, itching, or dryness. Consultation with a healthcare professional is recommended prior to initiation, especially in individuals with hypersensitivity or contraindications to either component.